ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
74.87
0.48
(0.65%)
終了 11月27日 6:00AM
74.87
0.01
(0.01%)
取引時間後: 6:15AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
74.87
買値
73.79
売値
75.88
出来高
993,856
72.725 日の範囲 75.13
61.16 52 週間の範囲 85.57
時価総額
前日終値
74.39
始値
73.81
最終取引時間
財務取引量
US$ 73,959,533
VWAP
74.4168
平均取引量 (3 か月)
936,001
発行済株式数
158,891,800
配当利回り
0.43%
PER
70.76
1 株当たり利益 (EPS)
1.06
歳入
1.16B
純利益
168.11M

Bio Techne Corporation について

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. 詳細を表示

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Minneapolis, Minnesota, USA
設立
-
Bio Techne Corporation is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker TECH. The last closing price for Bio Techne was US$74.39. Over the last year, Bio Techne shares have traded in a share price range of US$ 61.16 to US$ 85.57.

Bio Techne currently has 158,891,800 shares in issue. The market capitalisation of Bio Techne is US$11.82 billion. Bio Techne has a price to earnings ratio (PE ratio) of 70.76.

TECH 最新ニュース

Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne

Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne PR Newswire WEST SACRAMENTO, Calif., Nov. 25, 2024 WEST SACRAMENTO, Calif., Nov...

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES PR Newswire MINNEAPOLIS, Nov. 20, 2024 MINNEAPOLIS, Nov. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...

BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO

BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO PR Newswire MINNEAPOLIS, Nov. 14, 2024 Customers will present data from their use of...

UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS PR Newswire MINNEAPOLIS, Nov. 11, 2024 R&D Systems Hematology Controls and Calibrators has completed the Class...

BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS PR Newswire MINNEAPOLIS, Nov. 11, 2024 R&D Systems Hematology Controls and Calibrators has completed the Class C...

BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES

BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES PR Newswire MINNEAPOLIS, Nov. 8, 2024 MINNEAPOLIS, Nov. 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will...

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy PR Newswire ST. PAUL, Minn., Nov. 7...

BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING

BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING PR Newswire MINNEAPOLIS, Nov. 6, 2024 MINNEAPOLIS, Nov. 6, 2024 /PRNewswire/ -- Bio-Techne Corporation...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
18.14512.206819033366.7257565.61122885269.95893849CS
44.746.7588763724570.1379.8665.61121394672.24730862CS
121.1651.5806254663973.70580.949965.6193600173.27873792CS
26-5.93-7.3391089108980.883.6265.6196116974.30159183CS
5211.1217.443137254963.7585.5761.16103221272.87580557CS
156-44.24-37.1421375199119.11130.7451.7975826176.3593384CS
26019.7735.880217785855.1135.962538.792553869378.00604509CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
PSTXPoseida Therapeutics Inc
US$ 9.38
(227.97%)
30.14M
IMGCIMG Inc
US$ 1.615
(156.35%)
114.51M
IDAIT Stamp Inc
US$ 0.364
(102.22%)
560.18M
PGHLPrimega Group Holdings Ltd
US$ 20.95
(98.77%)
2.89M
TOYOTOYO Company Ltd
US$ 5.41
(86.55%)
49.09M
ALECAlector Inc
US$ 2.575
(-34.97%)
8.13M
ABVEAbove Food Ingredients Inc
US$ 0.5338
(-34.42%)
1.66M
LGCLLucas GC Ltd
US$ 0.7511
(-33.53%)
2.48M
ADDColor Star Technology Company Ltd
US$ 4.19
(-31.87%)
205.78k
LESLLeslies Inc
US$ 2.445
(-30.34%)
24.55M
IDAIT Stamp Inc
US$ 0.364
(102.22%)
560.18M
ELABElevai Labs Inc
US$ 0.01255
(-21.07%)
325.82M
NVDANVIDIA Corporation
US$ 136.92
(0.66%)
190.3M
RGTIRigetti Computing Inc
US$ 2.195
(-20.18%)
126.72M
IMGCIMG Inc
US$ 1.615
(156.35%)
114.51M

TECH Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock